ImmuCell Corporation Market Cap 2011-2026 | ICCC

As of May 07, 2026 ImmuCell Corporation has a market cap of $ 78.2 M

Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.^[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap ImmuCell Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
58 M	40.9 M	40.4 M	40.7 M	61.9 M	67.4 M	34.8 M	43.4 M	35.3 M	25 M	17.9 M	18.2 M	13.3 M	11.9 M	13.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
67.4 M	11.9 M	34.9 M

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer	Market Cap	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	50.7 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	315 M	-	2.43 %	$ 254 M	Germany
MannKind Corporation MNKD	990 M	$ 3.56	24.48 %	$ 1.09 B	USA
AgeX Therapeutics AGE	14.1 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	127 M	-	-	$ 866 M	China
Bio-Techne Corporation TECH	8.99 B	$ 47.41	-16.36 %	$ 7.47 B	USA
United Therapeutics Corporation UTHR	23.6 B	$ 596.76	4.29 %	$ 26.4 B	USA
Midatech Pharma plc MTP	79 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	33.6 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	549 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	28.9 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	1.62 M	-	-	$ 269 M	USA
BioNTech SE BNTX	62.9 B	-	-	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	2.83 B	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	52.7 M	-	-	$ 231 M	USA
INmune Bio INMB	28.2 M	$ 1.52	-1.3 %	$ 37.6 M	USA
Exelixis EXEL	11.7 B	$ 48.7	9.64 %	$ 13.2 B	USA
ACADIA Pharmaceuticals ACAD	3.19 B	$ 21.48	-3.89 %	$ 3.56 B	USA
Fortress Biotech FBIO	77.8 M	-	-	$ 71.1 M	USA
Advaxis ADXS	1.87 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	561 M	$ 3.15	1.19 %	$ 655 M	USA
Can-Fite BioPharma Ltd. CANF	4.81 M	-	-	$ 5.51 M	Israel
Aeterna Zentaris AEZS	41.4 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	724 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.53 B	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	32.8 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	19.6 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	3.25 B	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	2.32 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	9.48 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	172 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	538 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	114 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13.1 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	3.44 B	$ 24.17	3.2 %	$ 3.08 B	USA
Allena Pharmaceuticals ALNA	71.4 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	664 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	22.1 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	269 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	38.2 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	541 M	-	-	$ 8.42 M	USA
Aravive ARAV	60.4 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	4.13 M	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	4.39 B	$ 55.08	5.15 %	$ 4.95 B	Schweiz
Avenue Therapeutics ATXI	544 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	322 M	$ 1.7	3.66 %	$ 452 M	Britain
AVROBIO AVRO	56.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	7.72 M	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	661 M	-	-	-	Russia